Globalspace Technologies zooms on launching new product `PATGPT`
Globalspace Technologies is currently trading at Rs. 16.49, up by 0.83 points or 5.30% from its previous closing of Rs. 15.66 on the BSE.
The scrip opened at Rs. 15.79 and has touched a high and low of Rs. 17.22 and Rs. 15.70 respectively. So far 120274 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 24.99 on 16-Jan-2025 and a 52 week low of Rs. 14.32 on 07-Aug-2025.
Last one week high and low of the scrip stood at Rs. 17.22 and Rs. 15.21 respectively. The current market cap of the company is Rs. 56.44 crore.
The promoters holding in the company stood at 55.84%, while Non-Institutions held 44.16% stake in the company.
Globalspace Technologies has launched a new product ‘PATGPT - A Pharma-specific Large Language Model (LLM) Platform. PATGPT is a ready-to-deploy AI solution designed specifically for pharmaceutical enterprises. It will operate under a hybrid model wherein 50% of the training has been carried out on pharmaceutical datasets by GlobalSpace, and the remaining 50% will be trained using proprietary datasets of pharmaceutical companies within their secure cloud environments.
This approach positions PATGPT both as a product and as a customized LLM training service, enabling pharma companies to securely build organization-specific AI intelligence. In the initial phase, PATGPT will focus on sales, marketing, inventory, and distribution optimization. The future roadmap includes expansion into R&D, clinical trials, pharmacovigilance, and regulatory submissions.
Globalspace Technologies is a Software Product Platform Company with focus on Enterprise Mobility SaaS based solutions, providing integrated software & hardware product platforms and solutions to enable large and medium enterprises embrace mobility & digital technology for their business enhancement.
